No Matches Found
No Matches Found
No Matches Found
Fresh Tracks Therapeutics, Inc.
What does Fresh Tracks Therapeutics, Inc. do?
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing therapeutics for skin diseases, with a market cap of $5.58 million and a recent net profit of -$1 million. The company operates in the micro-cap sector and has key financial metrics indicating significant losses and a high dividend yield.
How big is Fresh Tracks Therapeutics, Inc.?
As of Feb 28, Fresh Tracks Therapeutics, Inc. has a market capitalization of 5.58 million, with net sales of 8.00 million and a net profit of -5.89 million over the last four quarters. As of December 2023, the company has total assets of 11.59 million and shareholder's funds of 9.93 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

